Jonsson Comprehensive Cancer Center: all 398 studies

Page 3 of 4. Open to participants first (67), then studies with results posted, then the rest; newest registration first within each.

• Compassionate Use of MitoGel in Upper Tract Urothelial CarcinomaNo longer availableNCT02701023
• Quality of Life After Bladder-Preservation Chemotherapy and Radiation Therapy in Patients With Muscle-Invasive Bladder CancerWithdrawnNCT02688348Not applicable
• MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver CancerCompletedNCT02683200Early Phase 1
• Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic CancerTerminatedNCT02681601Not applicable
• Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid NodulesActive, not recruitingNCT02681328
• Targeted Biopsies in Determining Response in Patients With Prostate Cancer Undergoing High-Dose-Rate BrachytherapyWithdrawnNCT02597894Not applicable
• Palliative 4pi Radiotherapy in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNCT02575027Not applicable
• Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung CancerWithdrawnNCT02451865Phase 1
• Prospective Assessment of Image Registration for the Diagnosis of Prostate CancerCompletedNCT02425228
• Focal Laser Ablation of Prostate TissueCompletedNCT02357121Early Phase 1
• Anti-tumor Immune Response in Patients With Cancer Undergoing Radiation TherapyTerminatedNCT02310594
• Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate CancerActive, not recruitingNCT02296229Not applicable
• Intermittent LGX818 and MEK162 in Treating Patients With Metastatic Melanoma Who Have BRAFV600 MutationsWithdrawnNCT02263898Phase 2
• Predictors of Patient Attitudes and Barriers to Skin Cancer ScreeningCompletedNCT02235116
• Use of Laser Interstitial Thermal Therapy in the Focal Treatment of Localized Prostate CancerCompletedNCT02224911
• Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate CancerActive, not recruitingNCT02176902Not applicable
• 68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)No longer availableNCT02174679
• Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic CancerCompletedNCT02092948Phase 1
• Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic MalignanciesTerminatedNCT02070406Phase 1
• PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT02049593Phase 1
• Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx CancerCompletedNCT02048020Phase 2
• Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving EverolimusCompletedNCT02015559Phase 2
• Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate CancerActive, not recruitingNCT01990196Phase 2
• Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing SurgeryCompletedNCT01912820Phase 1
• Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's PerspectiveCompletedNCT01873248Early Phase 1
• Internal Radiation Therapy in Treating Patients With Low-Risk Prostate CancerWithdrawnNCT01859689Phase 2
• Autologous Dendritic Cells in Treating Patients With Metastatic Kidney CancerCompletedNCT01826877Phase 1
• Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II MelanomaWithdrawnNCT01826864Phase 3
• Response Monitoring Trial in Patients With Suspected Recurrence of GlioblastomaCompletedNCT01813877Not applicable
• Pemetrexed Disodium and Hsp90 Inhibitor AUY922 in Treating Patients With Previously Treated Stage IV Non-Small Cell Lung CancerCompletedNCT01784640Phase 1
• Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS MetastasisCompletedNCT01783756Phase 1/2
• Gene and Vaccine Therapy in Treating Patients With Advanced MalignanciesActive, not recruitingNCT01697527Phase 2
• Exemestane, Pemetrexed Disodium, and Carboplatin in Treating Post-Menopausal Women With Stage IV Non-Small Cell Lung CancerCompletedNCT01664754Phase 1
• Study of Survivorship Care Plans and Outcomes in Underserved Breast Cancer SurvivorsCompletedNCT01627366Not applicable
• Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver CancerCompletedNCT01624285Phase 2
• Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma MultiformeCompletedNCT01591577Phase 2
• A Mindfulness Meditation-Based Intervention for Younger Breast Cancer SurvivorsCompletedNCT01558258Phase 2
• Cognitive Rehabilitation Group Intervention for Breast Cancer SurvivorsCompletedNCT01540955Phase 2
• A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 ExpressionCompletedNCT01536743Phase 2
• Breast Cancer Screening InterventionCompletedNCT01525264Not applicable
• FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell LymphomaCompletedNCT01410630
• Community Dissemination of an Evidence-based Colorectal Cancer (CRC) Screening InterventionCompletedNCT01351220Not applicable
• Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By SurgeryActive, not recruitingNCT01345851Not applicable
• Study of RAD001 for Treatment of NF2-related Vestibular SchwannomaTerminatedNCT01345136Phase 2
• Dendritic Cell Vaccine for Patients With Brain TumorsCompletedNCT01204684Phase 2
• The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patients With Cancer, Autoimmune/Inflammatory DiseasesCompletedNCT01180907
• The Biodistribution of 1-L-(2 Deoxy-2,- 18 Fluoroarabinofuranosyl) Cytosine ([18F]L-FAC) in Healthy Subjects and Patients With Cancer, Autoimmune and Inflammatory DiseasesCompletedNCT01180868
• Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or GliosarcomaCompletedNCT01149850Phase 2
• Cellular Immunotherapy Study for Brain CancerCompletedNCT01144247Phase 1
• Study of Sunitinib in Subjects With High Risk Renal Cell CarcinomaWithdrawnNCT01070186Phase 2
• Hypo-fractionated Stereotactic Body Radiotherapy for Localized Prostate CancerCompletedNCT01059513
• Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Non-Metastatic, Post Menopausal Breast Cancer PatientsCompletedNCT01051609
• Stereotactic Body Radiotherapy and Radiofrequency Ablation for Lung Tumors Near Central AirwaysCompletedNCT01051037Not applicable
• Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant MelanomaCompletedNCT01005472Phase 1
• Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemotherapy for Breast Cancer and in Healthy ParticipantsWithdrawnNCT00999557Not applicable
• Comparing Two Types of Swabs in Collecting Cell Samples for Anal Pap Tests and Human Papillomavirus Tests in Men Who Have Sex With MenCompletedNCT00955591Not applicable
• Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryWithdrawnNCT00882765Phase 2
• Low-Fat Fish Oil Diet for Prostate Cancer PreventionCompletedNCT00798876Not applicable
• Clinical Study of SU011248 in Subjects With High Risk Prostate Cancer Who Have Elected to Undergo Radical ProstatectomyCompletedNCT00790595Phase 1
• Informed Decision-Making Regarding Prostate Specific Antigen (PSA) Screening in 50-70 Year Old Latino MenCompletedNCT00761124Not applicable
• Increasing Adherence to Follow-up of Breast Abnormalities in Low-Income Korean American WomenCompletedNCT00742755Not applicable
• Increasing Colorectal Cancer Screening Among Filipino AmericansCompletedNCT00742729Not applicable
• A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before ProstatectomyCompletedNCT00719030Not applicable
• Vaccine Therapy in Treating Women With Previously Treated Metastatic Breast CancerWithdrawnNCT00706615Phase 1
• Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune MechanismsCompletedNCT00690196Not applicable
• Improving Fatigue: A Pilot Study of Acupuncture and Patient Education for Breast Cancer SurvivorsCompletedNCT00646633Not applicable
• Vaccine Therapy in Treating Patients With Malignant GliomaCompletedNCT00612001Phase 1
• Temozolomide in Treating Patients With Invasive Pituitary TumorsWithdrawnNCT00601289Phase 2
• Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNCT00601094Phase 1
• Patient-Directed Lifestyle Change and Health Promotion Program or Usual Care in Low-Income, Uninsured Participants in Los Angeles County, CaliforniaCompletedNCT00521209Not applicable
• Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant GliomaCompletedNCT00509431Phase 1
• Depression and Interleukin-6 Production in Patients With Ovarian Epithelial CancerWithdrawnNCT00460200
• Glucose Metabolism in Patients With Non-Small Cell Lung Cancer Treated With Targeted Therapy and ChemotherapyCompletedNCT00450567
• Fluorine F 18 FEQA in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer and in Healthy ParticipantsTerminatedNCT00444223Not applicable
• T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid TumorsCompletedNCT00433407Not applicable
• Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast CancerTerminatedNCT00427427Phase 2
• Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning AloneCompletedNCT00351728
• Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 BrachytherapyTerminatedNCT00346372
• Dasatinib in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphoblastic LeukemiaCompletedNCT00345826Phase 1
• Cytogenetic Study of Ocular MelanomaCompletedNCT00344799
• PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL TherapyStatus unknownNCT00335868Phase 2
• PET Scan Combined With CT Scan in Evaluating Treatment Response in Patients Undergoing Treatment for Bone Cancer or Soft Tissue SarcomaCompletedNCT00335751Not applicable
• AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaStatus unknownNCT00324597Phase 1
• Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney CancerStatus unknownNCT00301990Phase 2
• Volociximab and Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00278187Phase 2
• Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for CancerCompletedNCT00255749Phase 2
• Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By SurgeryWithdrawnNCT00253617Phase 3
• Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic SyndromesTerminatedNCT00234000Phase 1
• Denileukin Diftitox in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00138164Phase 2
• Eculizumab in Treating Patients With Paroxysmal Nocturnal HemoglobinuriaCompletedNCT00112983Phase 3
• BMS-354825 or Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib MesylateStatus unknownNCT00112775Phase 2
• Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast CancerTerminatedNCT00112749Phase 2
• Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery for Malignant GliomaCompletedNCT00107185Phase 1
• Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV MelanomaCompletedNCT00107159Phase 2
• Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00104767Phase 1
• 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Imatinib MesylateCompletedNCT00100997Phase 1
• Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung CancerTerminatedNCT00098917Phase 1
• Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung CancerWithdrawnNCT00098462Phase 1/2
• CP-547,632 in Treating Patients With Recurrent or Persistent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerCompletedNCT00096239Phase 2
• Monoclonal Antibody HuHMFG1 in Treating Women With Locally Advanced or Metastatic Breast CancerCompletedNCT00096057Phase 1

← Jonsson Comprehensive Cancer Center overview and focus areas